Get the Stockscreener App
41.48
0.60%
-0.25
After Hours:
42.61
1.13
+2.72%
Springworks Therapeutics Inc Stock (SWTX) Financials Data
Income Statement
Quarterly
*All numbers in millions
| Period End Date | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
| Revenues |
285.64%
21.01
|
5.447 | - | - | - |
| Cost Of Revenue |
1.202
|
- | - | - | - |
| Gross Profit |
19.80
|
- | - | - | - |
Operating Expenses
|
9.90%
113.73
|
103.49 | 84.00 | 82.85 | 77.70 |
| Benefits Costs and Expenses |
114.94
|
- | - | - | - |
| Costs And Expenses |
114.94
|
- | - | - | - |
| Operating Income/Loss |
4.60%
-93.93
|
-98.46 | -84.00 | -82.85 | -77.70 |
| Nonoperating Income/Loss |
26.69%
7.571
|
5.976 | 5.586 | 5.828 | 5.557 |
| Income/Loss Before Equity Method Investments |
15.84%
-92.91
|
-110.40 | -78.41 | -77.02 | -72.14 |
| Income/Loss From Equity Method Investments |
44.14%
-1.025
|
-1.835 | -1.024 | -0.901 | -1.278 |
| Income/Loss From Continuing Operations Before Tax |
16.31%
-93.93
|
-112.23 | -79.44 | -77.92 | -73.42 |
| Income/Loss From Continuing Operations After Tax |
7.35%
-87.39
|
-94.32 | -79.44 | -77.92 | -73.42 |
|
Net Income/Loss
|
7.35%
-87.39
|
-94.32 | -79.44 | -77.92 | -73.42 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
9,903%
73.77
|
0.7374 | 62.52 | 62.46 | 62.33 |
| Diluted Average Shares |
9,903%
73.77
|
0.7374 | 62.52 | 62.46 | 62.33 |
| Basic Earnings Per Share |
18.62%
-1.18
|
-1.45 | -1.27 | -1.25 | -1.18 |
| Diluted Earnings Per Share |
18.62%
-1.18
|
-1.45 | -1.27 | -1.25 | -1.18 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.61%
1.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):